急性呼吸窘迫综合征中的右心室:预后、病理生理与诊疗现状
该综述聚焦中重度ARDS中右心室功能障碍(RVD),指出RVD在ARDS中超声检出率为22%–50%,严重RVD与死亡率增加相关。影响右室功能的因素包括缺氧性肺血管收缩、高碳酸血症和高驱动压机械通气。现有超声指标尚未在足够把握度的研究中验证,诊断与治疗均存在证据缺口。
要点
- ARDS合并严重RVD与死亡率增加相关,但RVD与死亡无确切因果关系。
- 缺氧性肺血管收缩、高碳酸血症和高驱动压通气可损害右室功能。
- 用于ARDS右室评估的超声指标尚未在足够把握度的研究中验证。
核心结论
- ARDS患者合并严重右心室功能障碍与死亡率增加相关,但RVD与死亡之间尚无确切因果关系。
研究设计与样本
- 本文为综述,评估ARDS中右心室功能障碍的预后意义、病理生理、诊断方法与治疗选择。
主要发现
- ARDS尽管采用最佳标准治疗,合并死亡率仍约为40%。
- 中重度ARDS中右心室功能障碍常见,超声心动图可检出的RVD患病率在不同研究中为22%至50%。
- 缺氧性肺血管收缩、高碳酸血症和高驱动压有创通气是可对右室功能产生不利影响的因素。
- 用于前瞻性评估ARDS右心的超声心动图定性及定量指标尚未在足够把握度的研究中验证。
临床怎么用
- 对中重度ARDS应关注右心室功能,可通过超声心动图评估RVD。
- 管理上需注意避免高驱动压通气等可损害右室功能的因素。
局限性
- RVD与死亡率之间无确切因果关系。
- 用于ARDS右室评估的超声指标缺乏足够把握度的研究验证。
- RVD患病率在不同研究间存在差异(22%至50%)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ARDS is associated with poor clinical outcomes, with a pooled mortality rate of approximately 40% despite best standards of care. Current therapeutic strategies are based on improving oxygenation and pulmonary compliance while minimizing ventilator-induced lung injury. It has been demonstrated that relative hypoxemia can be well tolerated, and improvements in oxygenation do not necessarily translate into survival benefit. Cardiac failure, in particular right ventricular dysfunction (RVD), is commonly encountered in moderate to severe ARDS and is reported to be one of the major determinants of mortality. The prevalence rate of echocardiographically evident RVD in ARDS varies across studies, ranging from 22% to 50%. Although there is no definitive causal relationship between RVD and mortality, severe RVD is associated with increased mortality. Factors that can adversely affect RV function include hypoxic pulmonary vasoconstriction, hypercapnia, and invasive ventilation with high driving pressure. It might be expected that early diagnosis of RVD would be of benefit; however, echocardiographic markers (qualitative and quantitative) used to prospectively evaluate the right ventricle in ARDS have not been tested in adequately powered studies. In this review, we examine the prognostic implications and pathophysiology of RVD in ARDS and discuss available diagnostic modalities and treatment options. We aim to identify gaps in knowledge and directions for future research that could potentially improve clinical outcomes in this patient population.
引用
- Zochios V, Parhar K, Tunnicliffe W, et al. The Right Ventricle in ARDS. Chest. 2017. PMID: 28267435. doi:10.1016/j.chest.2017.02.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。